Chlorhexidine hydrochloride and nystatin are combined in a topical or oral formulation to provide both antimicrobial and antifungal effects. Chlorhexidine is a broad-spectrum antiseptic, while nystatin is an antifungal medication effective against Candida species.
This combination is used for:
| Brand Name | Nystaderm |
|---|---|
| Type | Cream |
| Weight | 1%+2% |
| Generic | Chlorhexidine hydrochloride + Nystatin |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available in | English বাংলা |
The mechanism of action involves:
Relief from symptoms such as oral thrush typically begins within a few days of starting the treatment. The full effect can be seen over a week of consistent use.
Chlorhexidine is minimally absorbed when applied topically or used as a mouth rinse. Nystatin is poorly absorbed from the gastrointestinal tract, making it effective primarily at the site of application.
Chlorhexidine is excreted mainly through the feces with minimal systemic absorption. Nystatin is excreted in the feces, and its systemic absorption is minimal.
The dosage varies based on the formulation and condition being treated:
For oral infections, use the oral suspension as directed, swishing it around the mouth and swallowing. For topical infections, apply the medication directly to the affected area, ensuring the skin is clean and dry before application.
Possible side effects include:
Toxicity is rare with appropriate use, but excessive ingestion or application to large areas may cause systemic effects. In case of overdose or severe side effects, seek medical attention.
Precautions include:
Drug interactions are unlikely with topical use due to minimal systemic absorption. Inform healthcare providers of all medications being used to avoid potential interactions.
Use with caution in patients with known allergies to any of the components or in individuals with severe oral or skin infections where systemic treatment may be needed.
Interactions are unlikely due to minimal systemic absorption. However, inform healthcare providers of any concurrent medications to avoid possible interactions.
There are no significant food interactions reported with this medication.
The safety of this combination during pregnancy has not been well-established. Use only if clearly needed and consult a healthcare provider for guidance.
It is not known if this combination is excreted in breast milk. Use during lactation should be considered only if the benefits outweigh the risks. Consult a healthcare provider for advice.
Acute overdose is unlikely with topical application or oral use as directed. In case of accidental ingestion or significant overdose, seek medical attention immediately.
Contraindications include:
Apply or use the medication as directed. For oral suspensions, swish around the mouth and swallow. For topical use, apply a thin layer to the affected area. Follow specific instructions provided with the product or by a healthcare provider.
Store the product in a cool, dry place away from direct sunlight. Keep the container tightly closed and out of reach of children.
Due to topical or oral application, systemic distribution is minimal. The active ingredients primarily act locally at the site of application.
The half-life of chlorhexidine and nystatin in systemic circulation is not typically relevant due to minimal systemic absorption. The effects are primarily localized to the site of application.
Chlorhexidine is cleared through the feces with minimal systemic absorption. Nystatin is also cleared via the feces and has minimal systemic absorption.
See in details version Nystaderm Cream 1%+2% also Nystaderm Cream 1%+2% in bangla